LETTER
Cross-Coupling Hydroxymethylation
545
(m, 1 H), 8.13 (m, 2 H). 13C NMR (CDCl3): δ = 64.69, 116.66,
128.70, 128.72, 129.89, 133.89, 160.56, 163.43, 165.57, 169.68.
MS (EI): m/z (%) = 105 (100), 77 (50), 51 (30). HRMS (EI): m/z
calcd for C12H8N2O2Cl2: 281.9962; found: 281.9953. IR (CCl4):
2942, 1737, 1561, 1535, 1264, 1109 cm–1. Anal. Calcd (%) for
C12H8N2O2Cl2 (283.1): C, 50.91; H, 2.72; N, 9.89. Found: C, 50.63;
H, 2.72; N, 9.89.
action of 5b with 4 equivalents of 1 gave still preferential-
ly monosubstituted product 6b (72%) and only small
amount of the disubstituted compound 7b (21–24%).
Also the mono- and di(benzoyloxymethyl)pyrimidines 6
and 7 were deprotected to the desired hydroxymethylpyri-
midines using NaOMe in methanol. The deprotection on
pyrimidines 6a and 7a,b proceeded at 0 °C to avoid nu-
cleophilic substitutions on chloro substituents in a basic
media (Scheme2, Table2).
1
Compound 7b: yield 24% as yellowish crystals, mp 53–55 °C. H
NMR (CDCl3): δ = 5.44 (d, 4 H), 7.46 (m, 4 H), 7.46 (t, 1 H), 7.60
(m, 2 H), 8.04 (m, 4 H). 13C NMR (CDCl3): δ = 65.05, 112.61,
128.60, 128.96, 129.72, 133.62, 165.59, 169.28. MS (EI): m/z
(%) = 105 (100), 77 (55), 41 (25). HRMS (EI): m/z calcd for
C20H15N2O4Cl: 382.0720; found: 382.0724.
In conclusion, we have shown that the (benzoyloxy)meth-
ylzinc iodide is a suitable reagent for cross-coupling hy-
droxymethylation of certain aryl halides. However, the
scope of the reaction is quite narrow. The reaction pro-
ceeds only in electron-deficient aryl halides and the most
efficient it is for hydroxymethylation of 2-haloazines.
General Procedure for Deprotection
A 1 M methanolic NaOMe (50 µL, 0.05 mmol) was added to a so-
lution of a benzoylated compounds 3a–g, 6a,b, and 7a,b (0.25
mmol) in MeOH (15 mL) and the mixture was stirred at ambient
temperature. After complete deprotection the solvent was evaporat-
ed and the residue was chromatographed (CHCl3–MeOH).
Compound 4d: yield 96% as yellow oil. 1H NMR (CDCl3): δ = 3.64
(s, 1 H), 4.83 (s, 2 H), 8.47–8.53 (m), 8.64 (s, 1 H). 13C NMR
(CDCl3): δ = 62.77, 142.95, 143.43, 143.45, 154.95. MS (EI): m/z
(%) = 109 (20), 80 (20), 31 (90).
Compound 4g: yield 75% as white crystals, mp 93–94 °C. 1H NMR
(CDCl3): δ = 3.36 (s, 1 H), 4.81 (s, 2 H), 8.79 (s, 2 H). 13C NMR
(CDCl3): δ = 64.23, 118.46, 157.65, 166.60. MS (EI): m/z (%) = 187
(35), 158 (50), 52 (45). Anal. Calcd (%) for C5H5BrN2O (189.0): C,
31.77; H, 2.67; N, 14.82. Found: C, 31.78; H, 2.64; N, 14.39.
General Procedure for Cross-Couplings of 1 with Aryl Halides
A solution of (benzoyloxymethyl)zinc iodide (1, 3 mmol) in THF
was added at r.t. to a solution of an aryl halide (2a–n, 5a–d, 1
mmol), Pd(PPh3)4 (58 mg) in THF (2 mL) and stirred at r.t. for 6–8
h. The reaction was quenched with 1 M NaH2PO4 (30 mL) and ex-
tracted with CHCl3 (3 × 25 mL). Collected organic phases were
dried over MgSO4, filtered, and the solvent was evaporated. The
crude oily product was purified by chromatography.
1
Compound 3d: yield 96%, yellowish crystals, mp 45.5–47 °C. H
NMR (CDCl3): δ = 5.53 (s, 2 H), 7.46 (m, 2 H), 7.59 (m, 1 H), 8.11
(m, 2 H), 8.56–8.61 (m, 2 H), 8.79 (s, 1 H). 13C NMR (CDCl3): δ =
65.09, 128.48, 129.38, 129.79, 133.39, 143.66, 144.07, 144.13,
151.59, 166.03. MS (EI): m/z (%) = 105 (100), 77 (65), 51 (30).
HRMS (EI): m/z calcd for C12H10N2O2: 214.0742; found: 214.0748.
Compound 8a: yield 72% as yellow oil. 1H NMR (CDCl3): δ = 3.07
(s, 1 H), 4.78 (s, 2 H), 7.47 (s, 1 H), 8.93 (s, 1 H). 13C NMR (CDCl3):
δ = 63.60, 118.10, 158.20, 161.77, 170.43. MS (EI): m/z (%) = 143
(100), 115 (40), 52 (40). HRMS (EI): m/z calcd for C5H5N2OCl:
144.0090; found: 144.0087.
Compound 9a: yield 76% as yellow oil. 1H NMR (CDCl3): δ = 4.55
(d, 4 H), 5.67 (t, 2 H), 7.70 (s, 1 H), 8.91 (s, 1 H). 13C NMR (CDCl3):
δ = 63.30, 113.03, 156.65, 171.01. MS (EI): m/z (%) = 139 (100),
111 (100), 52 (70). HRMS (EI): m/z calcd for C6H8N2O2: 140.0585;
found: 140.0582.
1
Compound 3f: yield 68% as yellowish crystals, mp 76–77 °C. H
NMR (CDCl3): δ = 5.70 (s, 2 H), 7.47 (m, 2 H), 7.60 (m, 1 H), 7.76–
7.84 (m, 2 H), 8.08–8.17 (m, 3 H), 9.05 (s, 1 H). 13C NMR (CDCl3):
δ = 66.03, 128.54, 129.30, 129.37, 129.45, 129.89, 130.16, 130.45,
133.46, 141.84, 142.23, 144.22, 151.01, 166.16. MS (EI): m/z
(%) = 265 (25), 181 (30), 91 (40). HRMS (EI): m/z calcd for
C16H13N2O2: 265.0977; found: 265.0984. IR (CCl4): 3071, 1730,
1603, 1494, 1452, 1264, 1108 cm–1.
1
Compound 8b: yield 35% as white solid, mp 94–96 °C. H NMR
(CDCl3): δ = 2.79 (t, 1 H), 4.77 (dd, 2 H), 7.47 (t, 1 H). 13C NMR
(CDCl3): δ = 63.65, 116.42, 160.17, 163.10, 173.77. MS (EI): m/z
(%) = 177 (100), 148 (45), 113 (55).
Compound 3g: yield 96% as yellow oil. 1H NMR (CDCl3): δ = 5.52
(s, 2 H), 7.46 (m, 2 H), 7.58 (m, 1 H), 8.13 (m, 2 H), 8.77 (s, 2 H).
13C NMR (CDCl3): δ = 65.87, 119.04, 128.42, 129.62, 129.91,
133.25, 157.95, 163.43, 166.22. MS (EI): m/z (%) = 105 (100), 77
(65), 51 (40). HRMS (EI): m/z calcd for C12H9N2O2Br: 291.9847;
found: 291.9842.
Compound 9b: yield 74% as white solid, mp 165–172 °C. 1H NMR
(DMSO-d6): δ = 4.54 (d, 4 H), 5.79 (t, 2 H), 7.68 (s, 1 H). 13C NMR
(DMSO-d6): δ = 62.94, 112.16, 158.49, 175.38. MS (EI): m/z (%) =
173 (60), 145 (50), 32 (95).
Compound 6a: yield 43% as beige crystals, mp 79–80 °C. 1H NMR
(CDCl3): δ = 5.46 (d, 2 H, J = 0.8, CH2), 7.47 (dt, 1 H), 7.52 (m, 2
H), 7.65 (m, 1 H), 8.14 (m, 2 H), 8.98 (d, 1 H). 13C NMR (CDCl3):
δ = 65.07, 118.42, 128.67, 128.95, 129.86, 133.75, 158.63, 162.16,
165.73, 166.83. MS (EI): m/z (%) = 105 (100), 77 (50), 51 (30).
HRMS (EI): m/z calcd for C12H9N2O2Cl: 248.0352; found:
248.0360. IR (CCl4): 3064, 1734, 1569, 1540, 1267, 1112 cm–1.
Acknowledgment
This work is a part of the research project Z4 055 0506. It was sup-
ported by the ‘Centre for New Antivirals and Antineoplastics’
(1M0508), by the Programme for Targeted Research
(1QS400550501) and by Gilead Sciences, Inc.
Compound 7a: yield 54% as yellowish crystals, mp 109–113 °C. 1H
NMR (CDCl3): δ = 5.48 (d, 4 H), 7.42 (m, 4 H), 7.55 (dt, 1 H), 7.60
(m, 2 H), 8.07 (m, 4 H, 2 × H-o-Ph), 9.17 (s, 1 H). 13C NMR
(CDCl3): δ = 65.51, 114.24, 128.56, 129.17, 129.72, 133.50,
158.27, 165.75, 165.78. MS (EI): m/z (%) = 304 (10), 105 (100), 77
(55), 51 (15). HRMS (EI): m/z calcd for C20H16N2O4: 348.1110;
found: 348.1122. IR (CCl4): 2945, 1734, 1595, 1272, 1111 cm–1.
References
(1) Examples: (a) Casiraghi, G.; Casnati, G.; Puglia, G.; Sartori,
G. Synthesis 1980, 124. (b) Branytska, O.; Neumann, R.
Synlett 2004, 1575. (c) Armandi, M.; Bonelli, B.; Garrone,
E.; Ardizzi, M.; Cavani, F.; DaPozzo, L.; Maselli, L.;
Mezzogori, R.; Calestani, G. Appl. Catal., B: Environ. 2007,
70, 585.
1
Compound 6b: yield 72% as yellowish crystals, mp 69–70 °C. H
NMR (CDCl3): δ = 5.44 (d, 2 H), 7.38 (t, 1 H), 7.52 (m, 2 H), 7.66
Synlett 2008, No. 4, 543–546 © Thieme Stuttgart · New York